Literature DB >> 22704622

Plasmacytoid dendritic cells are productively infected and activated through TLR-7 early after arenavirus infection.

Mónica Macal1, Gavin M Lewis, Stefan Kunz, Richard Flavell, James A Harker, Elina I Zúñiga.   

Abstract

The antiviral response is largely mediated by dendritic cells (DCs), including conventional (c) DCs that function as antigen-presenting cells, and plasmacytoid (p) DCs that produce type I interferons, making them an attractive target for viruses. We find that the Old World arenaviruses lymphocytic choriomeningitis virus clone 13 (LCMV Cl13) and Lassa virus bind pDCs to a greater extent than cDCs. Consistently, LCMV Cl13 targets pDCs early after in vivo infection of its natural murine host and establishes a productive and robust replication cycle. pDCs coproduce type I interferons and proinflammatory cytokines, with the former being induced in both infected and uninfected pDCs, demonstrating a dissociation from intrinsic virus replication. TLR7 globally mediates pDC responses, limits pDC viral load, and promotes rapid innate and adaptive immune cell activation. These early events likely help dictate the outcome of infections with arenaviruses and other DC-replicating viruses and shed light on potential therapeutic targets.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22704622      PMCID: PMC3377983          DOI: 10.1016/j.chom.2012.04.017

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  69 in total

Review 1.  Burnet oration: dendritic cells: multiple subtypes, multiple origins, multiple functions.

Authors:  K Shortman
Journal:  Immunol Cell Biol       Date:  2000-04       Impact factor: 5.126

Review 2.  Lassa fever.

Authors:  J B McCormick; S P Fisher-Hoch
Journal:  Curr Top Microbiol Immunol       Date:  2002       Impact factor: 4.291

Review 3.  Innate immune responses to LCMV infections: natural killer cells and cytokines.

Authors:  C A Biron; K B Nguyen; G C Pien
Journal:  Curr Top Microbiol Immunol       Date:  2002       Impact factor: 4.291

Review 4.  Lymphocytic choriomeningitis virus and immunology.

Authors:  R M Zinkernagel
Journal:  Curr Top Microbiol Immunol       Date:  2002       Impact factor: 4.291

Review 5.  Arenaviruses. I. The epidemiology molecular and cell biology of arenaviruses. Introduction.

Authors:  Michael B A Oldstone
Journal:  Curr Top Microbiol Immunol       Date:  2002       Impact factor: 4.291

Review 6.  Arenaviruses: genomic RNAs, transcription, and replication.

Authors:  B J Meyer; J C de la Torre; P J Southern
Journal:  Curr Top Microbiol Immunol       Date:  2002       Impact factor: 4.291

Review 7.  Antigen-presentation properties of plasmacytoid dendritic cells.

Authors:  José A Villadangos; Louise Young
Journal:  Immunity       Date:  2008-09-19       Impact factor: 31.745

8.  Persistent virus infection inhibits type I interferon production by plasmacytoid dendritic cells to facilitate opportunistic infections.

Authors:  Elina I Zuniga; Li-Ying Liou; Lauren Mack; Marilyn Mendoza; Michael B A Oldstone
Journal:  Cell Host Microbe       Date:  2008-10-16       Impact factor: 21.023

9.  Visualization of IFNbeta production by plasmacytoid versus conventional dendritic cells under specific stimulation conditions in vivo.

Authors:  Stefanie Scheu; Philipp Dresing; Richard M Locksley
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-16       Impact factor: 11.205

10.  Interferon alpha/beta and interleukin 12 responses to viral infections: pathways regulating dendritic cell cytokine expression in vivo.

Authors:  Marc Dalod; Thais P Salazar-Mather; Lene Malmgaard; Casey Lewis; Carine Asselin-Paturel; Francine Brière; Giorgio Trinchieri; Christine A Biron
Journal:  J Exp Med       Date:  2002-02-18       Impact factor: 14.307

View more
  46 in total

1.  Lymphocytic Choriomeningitis Virus Differentially Affects the Virus-Induced Type I Interferon Response and Mitochondrial Apoptosis Mediated by RIG-I/MAVS.

Authors:  Christelle Pythoud; Sylvia Rothenberger; Luis Martínez-Sobrido; Juan Carlos de la Torre; Stefan Kunz
Journal:  J Virol       Date:  2015-04-01       Impact factor: 5.103

2.  Silica exposure and chronic virus infection synergistically promote lupus-like systemic autoimmunity in mice with low genetic predisposition.

Authors:  Rosana Gonzalez-Quintial; Jessica M Mayeux; Dwight H Kono; Argyrios N Theofilopoulos; Kenneth M Pollard; Roberto Baccala
Journal:  Clin Immunol       Date:  2019-06-05       Impact factor: 3.969

3.  Exonuclease domain of the Lassa virus nucleoprotein is critical to avoid RIG-I signaling and to inhibit the innate immune response.

Authors:  Stéphanie Reynard; Marion Russier; Alexandra Fizet; Xavier Carnec; Sylvain Baize
Journal:  J Virol       Date:  2014-09-24       Impact factor: 5.103

4.  Type I interferon is a therapeutic target for virus-induced lethal vascular damage.

Authors:  Roberto Baccala; Megan J Welch; Rosana Gonzalez-Quintial; Kevin B Walsh; John R Teijaro; Anthony Nguyen; Cherie T Ng; Brian M Sullivan; Alessandro Zarpellon; Zaverio M Ruggeri; Juan Carlos de la Torre; Argyrios N Theofilopoulos; Michael B A Oldstone
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-02       Impact factor: 11.205

5.  Critical role for interferon regulatory factor 3 (IRF-3) and IRF-7 in type I interferon-mediated control of murine norovirus replication.

Authors:  Larissa B Thackray; Erning Duan; Helen M Lazear; Amal Kambal; Robert D Schreiber; Michael S Diamond; Herbert W Virgin
Journal:  J Virol       Date:  2012-10-03       Impact factor: 5.103

6.  Is the TAM receptor Axl a receptor for lymphocytic choriomeningitis virus?

Authors:  Brian M Sullivan; Megan J Welch; Greg Lemke; Michael B A Oldstone
Journal:  J Virol       Date:  2013-01-16       Impact factor: 5.103

Review 7.  Innate and Adaptive Immune Regulation During Chronic Viral Infections.

Authors:  Elina I Zuniga; Monica Macal; Gavin M Lewis; James A Harker
Journal:  Annu Rev Virol       Date:  2015-09-02       Impact factor: 10.431

8.  Persistent LCMV infection is controlled by blockade of type I interferon signaling.

Authors:  John R Teijaro; Cherie Ng; Andrew M Lee; Brian M Sullivan; Kathleen C F Sheehan; Megan Welch; Robert D Schreiber; Juan Carlos de la Torre; Michael B A Oldstone
Journal:  Science       Date:  2013-04-12       Impact factor: 47.728

9.  Hematopoietic and nonhematopoietic cells promote Type I interferon- and TLR7-dependent monocytosis during low-dose LCMV infection.

Authors:  Matthew B Buechler; Griffin M Gessay; Shivani Srivastava; Daniel J Campbell; Jessica A Hamerman
Journal:  Eur J Immunol       Date:  2015-09-14       Impact factor: 5.532

10.  Engineering nanomaterials to address cell-mediated inflammation in atherosclerosis.

Authors:  Sean Allen; Yu-Gang Liu; Evan Scott
Journal:  Regen Eng Transl Med       Date:  2016-03-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.